Researchers identify an economic solution to Canada's opioid crisis
Nasal-administered naloxone is cost-effective and could help reduce the number of opioid-related fatalities compared to the current publicly funded intramuscular version, a new study has found.
Since 2016, Canada's opioid crisis has worsened, with over 40,000 opioid-related deaths, or about 22 deaths per day. Most of these accidental deaths (88 per cent) occur in British Columbia, Alberta and Ontario.